Michael Wagner

3.3k total citations
117 papers, 2.6k citations indexed

About

Michael Wagner is a scholar working on Molecular Biology, Organic Chemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Michael Wagner has authored 117 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 28 papers in Organic Chemistry and 20 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Michael Wagner's work include Diabetes Treatment and Management (17 papers), Synthesis and characterization of novel inorganic/organometallic compounds (13 papers) and Organometallic Complex Synthesis and Catalysis (13 papers). Michael Wagner is often cited by papers focused on Diabetes Treatment and Management (17 papers), Synthesis and characterization of novel inorganic/organometallic compounds (13 papers) and Organometallic Complex Synthesis and Catalysis (13 papers). Michael Wagner collaborates with scholars based in Germany, United States and Sweden. Michael Wagner's co-authors include Andreas Evers, Ulrich S. Schubert, M. Lorenz, Elisabeth Defoßa, Herman Schreuder, Klaus Jurkschat, Hans Matter, Volkmar Wehner, Marc Nazaré and Matthias Urmann and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and ACS Nano.

In The Last Decade

Michael Wagner

111 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Wagner Germany	30	936	757	471	339	239	117	2.6k
Michael F. Rohde United States	33	1.4k 1.5×	355 0.5×	216 0.5×	220 0.6×	213 0.9×	86	3.1k
Brigitte Guérin Canada	34	1.1k 1.1×	644 0.9×	127 0.3×	125 0.4×	128 0.5×	151	4.6k
Shoko Kume Japan	30	933 1.0×	789 1.0×	134 0.3×	315 0.9×	111 0.5×	90	3.4k
Jennifer L. Reid United States	19	1.3k 1.4×	427 0.6×	264 0.6×	447 1.3×	640 2.7×	31	2.7k
Maggie Ng Hong Kong	42	855 0.9×	823 1.1×	721 1.5×	167 0.5×	429 1.8×	136	4.5k
Song Xue China	28	944 1.0×	425 0.6×	257 0.5×	119 0.4×	179 0.7×	107	2.4k
Philip J. Bailey United Kingdom	30	726 0.8×	1.6k 2.1×	115 0.2×	1.1k 3.1×	186 0.8×	93	3.4k
Joseph A. Hrabie United States	22	583 0.6×	508 0.7×	55 0.1×	146 0.4×	154 0.6×	45	2.8k
Cynthia Hong United States	39	2.2k 2.3×	807 1.1×	262 0.6×	337 1.0×	1.8k 7.7×	56	5.6k
Masayuki Arakawa Japan	24	952 1.0×	243 0.3×	613 1.3×	86 0.3×	610 2.6×	78	2.8k

Countries citing papers authored by Michael Wagner

Since Specialization

Citations

This map shows the geographic impact of Michael Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Wagner more than expected).

Fields of papers citing papers by Michael Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Wagner. The network helps show where Michael Wagner may publish in the future.

Co-authorship network of co-authors of Michael Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Wagner. A scholar is included among the top collaborators of Michael Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Wagner. Michael Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Velikyan, Irina, Karl‐Henrik Grinnemo, Stefan James, et al.. (2025). Ga-68-Labeled Affibody Molecule-Based Radiopharmaceutical Targeting Platelet Derived Growth Factor Receptor Beta for Detection of Active Fibrosis in Patients with Myocardial Infarction. Pharmaceuticals. 18(12). 1833–1833.

Bailey, Justin J., Melinda Wuest, Michael Wagner, et al.. (2021). Synthesis and Preclinical Evaluation of [¹⁸F]SiFA-PSMA Inhibitors in a Prostate Cancer Model. Journal of Medicinal Chemistry. 64(21). 15671–15689. 10 indexed citations

Kannt, Aimo, Andreas Nygaard Madsen, Ralf Elvert, et al.. (2020). Incretin combination therapy for the treatment of non‐alcoholic steatohepatitis. Diabetes Obesity and Metabolism. 22(8). 1328–1338. 33 indexed citations

Eriksson, Olof, Torsten Haack, Youssef Hijazi, et al.. (2020). Receptor occupancy of dual glucagon-like peptide 1/glucagon receptor agonist SAR425899 in individuals with type 2 diabetes. Scientific Reports. 10(1). 16758–16758. 34 indexed citations

Mason, R. Preston, et al.. (2019). Progressive LDL Reduction to Very Low Levels Improves Dimeric Nitric Oxide Synthase, Nitric Oxide Bioavailability and Reduces Peroxynitrite in Endothelial Cells during Hyperglycemia. American Journal of Pharmacology and Toxicology. 14(1). 7–16. 5 indexed citations

Elvert, Ralf, Andreas W. Herling, Martin Bossart, et al.. (2018). Running on mixed fuel‐dual agonistic approach of GLP‐1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non‐human primates. Diabetes Obesity and Metabolism. 20(8). 1836–1851. 30 indexed citations

Evers, Andreas, Stefania Pfeiffer‐Marek, Martin Bossart, et al.. (2018). Peptide Optimization at the Drug Discovery-Development Interface: Tailoring of Physicochemical Properties Toward Specific Formulation Requirements. Journal of Pharmaceutical Sciences. 108(4). 1404–1414. 20 indexed citations

Mason, R. Preston, et al.. (2016). EICOSAPENTAENOIC ACID AND ATORVASTATIN ACTIVE METABOLITE, ALONE OR IN COMBINATION, REVERSED GLUCOSE- AND OXIDIZED LDL-INDUCED ENDOTHELIAL DYSFUNCTION MEASURED EX VIVO IN RATS. Journal of the American College of Cardiology. 67(13). 2320–2320. 3 indexed citations

Mason, Ronald P., et al.. (2016). AMLODIPINE INCREASES NITRIC OXIDE RELEASE IN ENDOTHELIAL CELLS COLLECTED FROM DONORS OF DIFFERENT RACES AND ENOS GENE VARIANTS. Journal of the American College of Cardiology. 67(13). 2321–2321. 2 indexed citations

10.

Capkun, Gorana, Frank Dahlke, Raquel Lahoz, et al.. (2015). Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database. Multiple Sclerosis and Related Disorders. 4(6). 546–554. 90 indexed citations

11.

Wettergreen, David, E. A. Grin, T. M. Hare, et al.. (2014). Subsurface Life in the Atacama: Overview of the First Autonomous Traverse of a 1-m Rover-Mounted Drill. Lunar and Planetary Science Conference. 1185. 1 indexed citations

12.

Press, Adrian T., Anja Traeger, Christian Pietsch, et al.. (2014). Cell type-specific delivery of short interfering RNAs by dye-functionalised theranostic nanoparticles. Nature Communications. 5(1). 5565–5565. 55 indexed citations

13.

Garidel, Patrick, Alfred Blume, & Michael Wagner. (2014). Prediction of colloidal stability of high concentration protein formulations. Pharmaceutical Development and Technology. 20(3). 367–374. 46 indexed citations

14.

Wagner, Michael, Christina Dietz, Jana Martincová, et al.. (2013). Insights into the Intramolecular Donor Stabilisation of Organostannylene Palladium and Platinum Complexes: Syntheses, Structures and DFT Calculations. Chemistry - A European Journal. 19(21). 6695–6708. 19 indexed citations

15.

Wagner, Michael, et al.. (2011). Intramolecularly coordinated heteroleptic organostannylene tungsten pentacarbonyl complexes 4-tBu-2,6-[P(O)(OiPr)2]2C6H2Sn(X)W(CO)5 (X = Cl, F, PPh2, PPh2[W(CO)5]). Syntheses and reactivity. Dalton Transactions. 40(35). 8839–8839. 36 indexed citations

16.

Wagner, Michael, Sebastian Dziadek, & Horst Kunz. (2003). The (2‐Phenyl‐2‐trimethylsilyl)ethyl‐(PTMSEL)‐Linker in the Synthesis of Glycopeptide Partial Structures of Complex Cell Surface Glycoproteins. Chemistry - A European Journal. 9(24). 6018–6030. 28 indexed citations

17.

Wagner, Michael & Horst Kunz. (2002). Der (2-Phenyl-2-trimethylsilyl)ethyl(PTMSEL)-Linker - ein neuer, mit Fluorid spaltbarer Anker für die Festphasensynthese von geschützten Peptiden und Glycopeptiden. Angewandte Chemie. 114(2). 315–319. 12 indexed citations

18.

Wagner, Michael & Horst Kunz. (2002). The (2-Phenyl-2-trimethylsilyl)ethyl(PTMSEL) Linker—A Novel Linker for the Solid-Phase Synthesis of Protected Peptides and Glycopeptides Cleavable with Fluoride This work was supported by the Volkswagen-Stiftung and by the Fonds der Chemischen Industrie. M.W. is grateful for a fellowship of the Boehringer-Ingelheim-Stiftung.. Angewandte Chemie International Edition. 41(2). 317–317. 31 indexed citations

19.

Wagner, Michael. (1999). The many faces of Pick's disease. Archives of Clinical Neuropsychology. 14(8). 617–617. 1 indexed citations

20.

Boll, M., et al.. (1995). Expression Cloning of a H+-Coupled High-Affinity Peptide Transporter (rhapt) From Rabbit Kidney Cortex. The FASEB Journal. 9(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact